...
首页> 外文期刊>Journal of Global Health >E-pharmacies in India: Can they improve the pharmaceutical service delivery?
【24h】

E-pharmacies in India: Can they improve the pharmaceutical service delivery?

机译:印度电子药店:他们可以改善制药服务吗?

获取原文

摘要

O f late, Indian e-pharmacies, despite their emerging popularity and growing customer base, have suffered at the hands of the Indian judiciary. Although e-pharmacy constitutes only 3% of phar- maceutical sales in India, it has been subject to hostility from retail pharmacists’ associations such as All India Organization of Chemists and Druggists (AIOCD). In an attempt to formalize the online sale of drugs, the Union Health Ministry has recently laid down certain guidelines that require e-pharmacies to be registered with Central Drugs Standard Control Organization (CDSCO), the chief licensing and reg- ulatory authority for pharmaceutical sales in India [1]. This move was met by strong retaliation from AIOCD, which even threatened to boycott the medicines marketed by those pharma-companies that in- vest in e-pharmacy [2].
机译:o F迟到,印度电子药店尽管他们的新兴人气和越来越多的客户群,所以在印度司法机构的手中遭受了遭受。虽然电子药房仅占印度法制销售的3%,但它受到零售药剂师协会的敌意,例如所有印度化学家和药剂师(AIOCD)。在试图将在线销售毒品形式化,联盟卫生部最近阐述了某些准则,要求在中央药物标准控制组织(CDSCO),制药销售的首席许可和统治权当局注册电子药品在印度[1]。这种举动得到了来自AIOCD的强烈报复,这甚至威胁要抵制那些在电子药物中的制药公司营销的药物[2]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号